Deakin University
Browse

Dissecting EXP2 sequence requirements for protein export in malaria parasites

Version 2 2024-06-19, 23:35
Version 1 2024-02-06, 04:10
journal contribution
posted on 2024-06-19, 23:35 authored by EL Pitman, Natalie CounihanNatalie Counihan, Joyanta ModakJoyanta Modak, M Chowdury, PR Gilson, CT Webb, Tania De Koning-WardTania De Koning-Ward
Apicomplexan parasites that reside within a parasitophorous vacuole harbor a conserved pore-forming protein that enables small-molecule transfer across the parasitophorous vacuole membrane (PVM). In Plasmodium parasites that cause malaria, this nutrient pore is formed by EXP2 which can complement the function of GRA17, an orthologous protein in Toxoplasma gondii. EXP2, however, has an additional function in Plasmodium parasites, serving also as the pore-forming component of the protein export machinery PTEX. To examine how EXP2 can play this additional role, transgenes that encoded truncations of EXP2, GRA17, hybrid GRA17-EXP2, or EXP2 under the transcriptional control of different promoters were expressed in EXP2 knockdown parasites to determine which could complement EXP2 function. This revealed that EXP2 is a unique pore-forming protein, and its protein export role in P. falciparum cannot be complemented by T. gondii GRA17. This was despite the addition of the EXP2 assembly strand and part of the linker helix to GRA17, which are regions necessary for the interaction of EXP2 with the other core PTEX components. This indicates that the body region of EXP2 plays a critical role in PTEX assembly and/or that the absence of other T. gondii GRA proteins in P. falciparum leads to its reduced efficiency of insertion into the PVM and complementation potential. Altering the timing and abundance of EXP2 expression did not affect protein export but affected parasite viability, indicating that the unique transcriptional profile of EXP2 when compared to other PTEX components enables it to serve an additional role in nutrient exchange.

History

Related Materials

Location

Lausanne, Switzerland

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Journal

Frontiers in Cellular and Infection Microbiology

Volume

13

Article number

1332146

Pagination

1-15

ISSN

2235-2988

eISSN

2235-2988

Publisher

Frontiers Media